StockTipsArenaBeta

BUY IOL Chemicals and Pharmaceuticals Limited — Kush Bohra

BUYIOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals share price target & all analyst calls

byKush BohraHorizon: Swing (≤2wk)11 Nov 2026via NDTV Profit (Live)

Entry₹208.42Inferred
Target₹215
Total upside +3.16% (call closed)
Stop loss₹200-4.04% risk
Exit₹20013 Nov 2026, 1:10 pm
Stop-loss hit-4.04%
Follow Kush Bohra for new calls(35% target hit, 229 closed calls)Get alertsWatch IOLCP for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Nov 2026
3 supporting1 neutral1 opposing
Supports the BUY call (3)

Up 118% in 6 months! This volume shocker pharma stock skyrockets 14% despite weak trends on Dalal Street Do you own?

NewsLivemint·9 Nov · 4d ago

(opens in new tab)

IOL Chemicals and Pharmaceuticals reported strong Q2 FY27 results with revenue of 795 crore (up 40.1% YoY), EBITDA of 114.9 crore (up 79.6% YoY), and PAT of 65 crore (up 116.8% YoY).

NSE · Press Release·30 Oct · 2w ago

(opens in new tab)

IOL Chemicals & Pharmaceuticals reported Q2 FY27 financial results with revenue of 795 Cr (up 40.1% YoY), EBITDA of 114.9 Cr (up 79.6% YoY), and PAT of 65 Cr (up 116.8% YoY).

BSE · Company Update·30 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (1)

Outcome of the Board Meeting and submission of Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026

BSE · Board Meeting·30 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·26 Oct · 3w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on IOL Chemicals and Pharmaceuticals

All analyst calls on IOL Chemicals and Pharmaceuticals

More from Kush Bohra

Every call and its outcome